Moleculin Secures Mexican Patent for Lung-Targeted Liposomal Annamycin; ATM Sales and Warrant Price Adjusted

Moleculin secured a Mexican patent for its lung-targeted liposomal Annamycin and reported ATM share sales and a reduced warrant exercise price.Key Highlights:Original SEC Filing: Moleculin Biotech, Inc. [ MBRX ] - 8-K - Sep. 23, 2026This is an AI-powered summary. It may contain inaccuracies. Consid…